Pulmonary fibrosis in COVID‐19 survivors: Predictive factors and risk reduction strategies

AS Ojo, SA Balogun, OT Williams… - Pulmonary medicine, 2020 - Wiley Online Library
Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …

Genetics insight for COVID-19 susceptibility and severity: a review

I Fricke-Galindo, R Falfán-Valencia - Frontiers in immunology, 2021 - frontiersin.org
Coronavirus disease (COVID-19) presents a broad spectrum of clinical manifestations
ranging from an asymptomatic to a severe clinical course. The host genetic background …

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

X Wu, X Liu, Y Zhou, H Yu, R Li, Q Zhan… - The Lancet …, 2021 - thelancet.com
Background The consequences of COVID-19 in those who recover from acute infection
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …

[HTML][HTML] European Respiratory Society statement on long COVID follow-up

KM Antoniou, E Vasarmidi, AM Russell… - European …, 2022 - publications.ersnet.org
Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …

[HTML][HTML] The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients

AG Fois, P Paliogiannis, V Scano, S Cau, S Babudieri… - Molecules, 2020 - mdpi.com
Background. The rapid onset of a systemic pro-inflammatory state followed by acute
respiratory distress syndrome is the leading cause of mortality in patients with COVID-19 …

Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

K Cares-Marambio… - Chronic respiratory …, 2021 - journals.sagepub.com
Knowledge on the sequelae of Coronavirus Disease 2019 (COVID-19) remains limited due
to the relatively recent onset of this pathology. However, the literature on other types of …

First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics

S Saito, Y Asai, N Matsunaga… - The Journal of …, 2020 - pmc.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, becomes
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure …

Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis

V Chidambaram, NL Tun, WZ Haque, MG Majella… - PloS one, 2020 - journals.plos.org
Background Understanding the factors associated with disease severity and mortality in
Coronavirus disease (COVID-19) is imperative to effectively triage patients. We performed a …

Clinical features and outcomes of HIV patients with coronavirus disease 2019

C Gervasoni, P Meraviglia, A Riva… - … diseases: an official …, 2020 - pmc.ncbi.nlm.nih.gov
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. All rights reserved. For …

Post covid 19 pulmonary fibrosis. Is it real threat?

DK Rai, P Sharma, R Kumar - Indian journal of tuberculosis, 2021 - Elsevier
After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …